Trending Articles – Dave G Plus http://davegplus.com/ Fri, 13 May 2022 03:27:32 +0000 en-US hourly 1 https://wordpress.org/?v=5.9.3 https://davegplus.com/wp-content/uploads/2021/04/default-138x136.png Trending Articles – Dave G Plus http://davegplus.com/ 32 32 Is Trending Stock Johnson & Johnson (JNJ) a buy it now? https://davegplus.com/is-trending-stock-johnson-johnson-jnj-a-buy-it-now/ Thu, 12 May 2022 13:00:06 +0000 https://davegplus.com/is-trending-stock-johnson-johnson-jnj-a-buy-it-now/ Johnson & Johnson (JNJ) is one of the most watched stocks by Zacks.com visitors lately. So it might be worth looking at some of the factors that could affect the stock’s short-term performance. Shares of the world’s largest maker of healthcare products have returned -2.5% over the past month compared to the -10.7% change in […]]]>

Johnson & Johnson (JNJ) is one of the most watched stocks by Zacks.com visitors lately. So it might be worth looking at some of the factors that could affect the stock’s short-term performance.

Shares of the world’s largest maker of healthcare products have returned -2.5% over the past month compared to the -10.7% change in the Zacks S&P 500 composite. Industry Zacks Large Cap Pharmaceuticals, to which belongs Johnson & Johnson, lost 7.5% over this period. Now the key question is: where could the stock be heading in the near term?

Although press releases or rumors about a substantial change in a company’s trading outlook will usually “trend” its stock and cause an immediate price change, there are always fundamental facts that ultimately dominate the take. purchase and retention decision.

Revisions to earnings estimates

Rather than focusing on anything else, at Zacks we prioritize assessing change in a company’s earnings projection. Indeed, we believe that the fair value of its shares is determined by the present value of its future earnings streams.

Our analysis is primarily based on how sell-side analysts covering the stock revise their earnings estimates to reflect the latest trading trends. When a company’s earnings estimates increase, the fair value of its stock also increases. And when the fair value of a stock is higher than its current market price, investors tend to buy the stock, causing its price to rise. For this reason, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term movements in stock prices.

Johnson & Johnson is expected to post earnings of $2.55 per share for the current quarter, representing a year-over-year change of +2.8%. Over the past 30 days, the Zacks consensus estimate has changed by -4.5%.

The current year earnings consensus estimate of $10.20 indicates a year-over-year change of +4.1%. This estimate has changed by -2.8% over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $10.75 indicates a change of +5.4% from what Johnson & Johnson is expected to report a year ago. Over the past month, the estimate has changed by +107.5%.

With an impressive externally audited track record, our proprietary stock rating tool – the Zacks Ranking – is a more conclusive indicator of a stock’s short-term price performance, as it effectively harnesses the power of earnings estimate revisions. . The magnitude of the recent consensus estimate change, along with three other factors related to earnings estimates, resulted in a Zacks #3 (Hold) ranking for Johnson & Johnson.

The chart below shows the evolution of the company’s consensus 12-month EPS estimate:

12 month EPS

Revenue Growth Forecasts

While a company’s earnings growth is arguably the best indicator of its financial health, nothing happens if it can’t grow its revenue. It is almost impossible for a company to increase its profits without increasing its revenue for long periods of time. Therefore, knowing the potential revenue growth of a business is crucial.

In the case of Johnson & Johnson, the consensus sales estimate of $23.79 billion for the current quarter indicates a year-over-year change of +2%. Estimates of $96.5 billion and $100.85 billion for the current and next fiscal year indicate changes of +2.9% and +4.5%, respectively.

Latest reported results and history of surprises

Johnson & Johnson posted revenue of $23.43 billion last quarter, representing a +5% year-over-year change. EPS of $2.67 for the same period versus $2.59 a year ago.

Compared to the Zacks consensus estimate of $23.75 billion, reported revenue is a surprise -1.37%. Surprise EPS was +2.69%.

The company has exceeded consensus EPS estimates in each of the past four quarters. The company exceeded consensus revenue estimates only once during this period.

Evaluation

Without considering the valuation of a stock, no investment decision can be effective. Crucial to predicting a stock’s future price performance is whether its current price accurately reflects the intrinsic value of the underlying business and the company’s growth prospects.

While comparing the current values ​​of a company’s valuation multiples, such as the price-to-earnings (P/E) ratio, the price-to-sales (P/S) ratio, and the price-to-cash flow (P/CF) ratio , along with its own historical values ​​help determine whether its stock is fairly valued, overvalued or undervalued, comparing the company against its peers on these metrics gives a good idea of ​​the reasonableness of the stock price .

As part of the Zacks Style Scores system, the Zacks Value Style Score (which assesses both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on.), which is useful in determining whether a stock is overvalued, correctly valued, or temporarily undervalued.

Johnson & Johnson is rated B on this front, indicating that it is trading at a discount to its peers. Click here to see values ​​for some of the rating metrics that led to this rating.

Conclusion

The facts discussed here and plenty of other information about Zacks.com might help determine whether it’s worth paying attention to the market buzz about Johnson & Johnson. However, its No. 3 Zacks ranking suggests it could perform in line with the broader market in the near term.

Just Released: Zacks Top 10 Stocks for 2022

In addition to the investment ideas discussed above, would you like to know our top 10 buy and hold tickers for all of 2022?

Last year 2021 Zacks Top 10 Stocks the portfolio generated gains as high as +147.7%. Now, a brand new portfolio has been selected from over 4,000 companies covered by the Zacks ranking. Don’t miss your chance to participate in this long term shopping

Access the Top 10 Zacks Stocks for 2022 today >>

Click to get this free report

Johnson & Johnson (JNJ): Free Stock Analysis Report

To read this article on Zacks.com, click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

]]>
Is Trending Stock Intel Corporation (INTC) a buy it now? https://davegplus.com/is-trending-stock-intel-corporation-intc-a-buy-it-now/ Tue, 10 May 2022 13:00:09 +0000 https://davegplus.com/is-trending-stock-intel-corporation-intc-a-buy-it-now/ Intel (INTC) recently made it to Zacks.com’s Most Wanted Stock list. Therefore, you may want to consider some of the key factors that may influence the stock’s performance in the near future. Over the past month, shares of the world’s largest chipmaker have returned -7.5%, compared to the -11% change in the Zacks S&P 500 […]]]>

Intel (INTC) recently made it to Zacks.com’s Most Wanted Stock list. Therefore, you may want to consider some of the key factors that may influence the stock’s performance in the near future.

Over the past month, shares of the world’s largest chipmaker have returned -7.5%, compared to the -11% change in the Zacks S&P 500 composite. During this period, industry Zacks Semiconductor – General, in which Intel belongs, lost 19.3%. The key question now is: what could be the future direction of the title?

Although press releases or rumors about a substantial change in a company’s business outlook will usually “trend” its stock and cause an immediate price change, there are always fundamental facts that ultimately dominate the take. purchase and retention decision.

Revisions to earnings estimates

Rather than focusing on anything else, at Zacks we prioritize assessing change in a company’s earnings projection. Indeed, we believe that the fair value of its shares is determined by the present value of its future earnings streams.

Our analysis is primarily based on how sell-side analysts covering the stock revise their earnings estimates to reflect the latest trading trends. When a company’s earnings estimates increase, the fair value of its stock also increases. And when the fair value of a stock is higher than its current market price, investors tend to buy the stock, causing its price to rise. For this reason, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term movements in stock prices.

Intel is expected to post earnings of $0.69 per share for the current quarter, representing a year-over-year change of -46.1%. Over the past 30 days, the Zacks consensus estimate has changed by -18.7%.

The consensus earnings estimate of $3.53 for the current fiscal year indicates a -35.5% year-over-year change. This estimate has changed by +1.1% over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $3.69 indicates a change of +4.6% from what Intel is expected to report a year ago. Over the past month, the estimate has changed by +139.3%.

With a strong externally audited track record, our proprietary stock rating tool, Zacks Rank, provides a more conclusive picture of a stock’s price direction in the short term, as it effectively harnesses the power of earnings estimate revisions. . Due to the magnitude of the recent consensus estimate change, along with three other factors related to earnings estimates, Intel is ranked Zacks Rank #3 (Hold).

The chart below shows the evolution of the company’s consensus 12-month EPS estimate:

12 month EPS

Expected revenue growth

While a company’s earnings growth is arguably the best indicator of its financial health, nothing happens if it can’t grow its revenue. It is almost impossible for a company to increase its profits without increasing its revenue for long periods of time. Therefore, knowing the potential revenue growth of a business is crucial.

In the case of Intel, the consensus sales estimate of $18.02 billion for the current quarter indicates a year-over-year change of -8.2%. Estimates of $75.55 billion and $78.72 billion for the current and next fiscal year indicate changes of -3.2% and +4.2%, respectively.

Latest reported results and history of surprises

Intel reported revenue of $18.35 billion last quarter, representing a -6.7% year-over-year change. EPS of $0.87 for the same period versus $1.39 a year ago.

Compared to the Zacks consensus estimate of $18.32 billion, reported revenue is a surprise +0.18%. Surprise EPS was +8.75%.

The company has exceeded consensus EPS estimates in each of the past four quarters. The company has exceeded consensus earnings estimates every time during this period.

Evaluation

Without considering the valuation of a stock, no investment decision can be effective. Crucial to predicting a stock’s future price performance is whether its current price accurately reflects the intrinsic value of the underlying business and the company’s growth prospects.

Compare the present value of a company’s valuation multiples, such as its price/earnings (P/E), price/sales (P/S), and price/cash flow (P/CF), to its own historical values ​​help determine whether its stock is fairly valued, overvalued or undervalued, while comparing the company against its peers on these metrics gives a good idea of ​​the reasonableness of its price.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which assesses both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on.), which helps determine whether a stock is overvalued, correctly valued, or temporarily undervalued.

Intel is rated A on this front, indicating that it is trading at a discount to its peers. Click here to see values ​​for some of the rating metrics that led to this rating.

Conclusion

The facts discussed here and plenty of other information on Zacks.com could help determine whether or not it’s worth paying attention to the market buzz about Intel. However, its No. 3 Zacks ranking suggests it could perform in line with the broader market in the near term.

Bitcoin, like the internet itself, could change everything

Blockchain and cryptocurrency have sparked one of the most exciting topics of discussion of a generation. Some call it the “internet of money” and predict that it could change the way money works forever. If true, it could do to banks what Netflix did to Blockbuster and Amazon did to Sears. Experts agree that we are still in the early stages of this technology and as it develops, it will create several investment opportunities.

Zacks just revealed 3 companies that can help investors capitalize on the explosive profit potential of Bitcoin and other cryptocurrencies with far less volatility than buying them outright.

See 3 Crypto-Related Stocks Now >>

Click to get this free report

Intel Corporation (INTC): Free Inventory Analysis Report

To read this article on Zacks.com, click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

]]>
A structure fire in Great Falls was ‘intentionally started’ https://davegplus.com/a-structure-fire-in-great-falls-was-intentionally-started/ Sun, 08 May 2022 22:50:00 +0000 https://davegplus.com/a-structure-fire-in-great-falls-was-intentionally-started/ (UPDATE, 4:45 p.m.) A structure fire in Great Falls on Sunday, May 8, 2022 was intentionally started, according to Great Falls Fire Rescue. The fire started in a vacant building located just behind Lippi’s Kitchen on Central Avenue West. The fire spread from the vacant building to three trailers on 7th Street Northwest. The fire […]]]>

(UPDATE, 4:45 p.m.) A structure fire in Great Falls on Sunday, May 8, 2022 was intentionally started, according to Great Falls Fire Rescue.

The fire started in a vacant building located just behind Lippi’s Kitchen on Central Avenue West. The fire spread from the vacant building to three trailers on 7th Street Northwest.

The fire caused minor exterior damage to the trailers; the monetary value of the damage has not been determined. The vacant building is considered a total loss.

None of the occupants of the trailers were injured; all residents were offered American Red Cross services.

Great Falls Fire Marshal Mike McIntosh said in a news release that “crews did an excellent job of stopping the fire from spreading to a trailer to the west, as well as the car wash. located next to the trailer”.

It was determined that the cause of the fire was intentionally started; there are no suspects in custody at this time. We’ll let you know if we get more information.


TRENDING ITEMS


(1st REPORT, 10:26 a.m.) Emergency crews responded to a structure fire in Great Falls on Sunday, May 8, 2022.

The fire was reported around 8:38 a.m. along 7th Street Northwest between Central Avenue West and 1st Avenue NW.

MTN

Emergency crews responded to a fire in Great Falls on Sunday, May 8, 2022

The fire appears to have started in one of the many mobile homes on the site.

The Great Falls Fire Rescue on-scene commander said firefighters conducted a sweep of all residences and found no people or pets inside, and no injuries were reported.

The fire was extinguished within an hour; the cause of the fire is still under investigation.

There is no word at this point on the amount of damage caused by the fire.

Great Falls Fire Rescue and the Great Falls Police Department responded to the incident.

]]>
Here’s what to know beyond why AbbVie Inc. (ABBV) is a trending stock https://davegplus.com/heres-what-to-know-beyond-why-abbvie-inc-abbv-is-a-trending-stock/ Thu, 05 May 2022 13:00:07 +0000 https://davegplus.com/heres-what-to-know-beyond-why-abbvie-inc-abbv-is-a-trending-stock/ AbbVie (ABBV) is one of the most watched stocks by visitors to Zacks.com lately. So it might be worth looking at some of the factors that could affect the stock’s short-term performance. Over the past month, shares of this drugmaker have returned -10.3%, compared to the -6.1% change in the Zacks S&P 500 composite. Pharmaceuticals, […]]]>

AbbVie (ABBV) is one of the most watched stocks by visitors to Zacks.com lately. So it might be worth looking at some of the factors that could affect the stock’s short-term performance.

Over the past month, shares of this drugmaker have returned -10.3%, compared to the -6.1% change in the Zacks S&P 500 composite. Pharmaceuticals, of which AbbVie is a part, gained 0.5%. The key question now is: what could be the future direction of the title?

Although press releases or rumors about a substantial change in a company’s trading outlook will usually “trend” its stock and cause an immediate price change, there are always fundamental facts that ultimately dominate the take. purchase and retention decision.

Revisions to earnings estimates

Rather than focusing on anything else, at Zacks we prioritize assessing change in a company’s earnings projection. Indeed, we believe that the fair value of its shares is determined by the present value of its future earnings streams.

We basically look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest trading trends. And if earnings estimates increase for a company, the fair value of its shares increases. A higher fair value than the current market price stimulates investors’ interest in buying the stock, causing its price to rise. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

AbbVie is expected to post earnings of $3.44 per share for the current quarter, representing a year-over-year change of +10.6%. Over the past 30 days, the Zacks consensus estimate has changed by -1.6%.

The current year earnings consensus estimate of $14.04 indicates a year-over-year change of +10.6%. This estimate has changed by -0.3% over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $11.84 indicates a -15.7% change from what AbbVie is expected to report a year ago. Over the past month, the estimate has changed by +104.1%.

With an impressive externally audited track record, our proprietary stock rating tool – the Zacks Ranking – is a more conclusive indicator of a stock’s short-term price performance, as it effectively harnesses the power of earnings estimate revisions. . The magnitude of the recent consensus estimate change, along with three other factors related to earnings estimates, resulted in a Zacks No. 3 (hold) ranking for AbbVie.

The chart below shows the evolution of the company’s consensus 12-month EPS estimate:

12 month EPS

Expected revenue growth

While a company’s earnings growth is arguably the best indicator of its financial health, nothing happens if it can’t grow its revenue. It is almost impossible for a company to increase its profits without increasing its revenue for long periods of time. Therefore, knowing the potential revenue growth of a business is crucial.

For AbbVie, the current quarter sales consensus estimate of $14.73 billion indicates a year-over-year change of +5.5%. For the current and future fiscal years, the estimates of $59.67 billion and $55.75 billion indicate variations of +6.2% and -6.6%, respectively.

Latest reported results and history of surprises

AbbVie recorded revenue of $13.54 billion in the last reported quarter, representing a year-over-year change of +4.1%. EPS of $3.16 for the same period versus $2.95 a year ago.

Compared to the Zacks consensus estimate of $13.55 billion, reported revenue is a surprise -0.09%. The EPS surprise was +0.32%.

Over the past four quarters, AbbVie has exceeded consensus EPS estimates three times. The company exceeded consensus revenue estimates only once during this period.

Evaluation

Without considering the valuation of a stock, no investment decision can be effective. Crucial to predicting a stock’s future price performance is whether its current price accurately reflects the intrinsic value of the underlying business and the company’s growth prospects.

While comparing the current values ​​of a company’s valuation multiples, such as the price-to-earnings (P/E) ratio, the price-to-sales (P/S) ratio, and the price-to-cash flow (P/CF) ratio , along with its own historical values ​​help determine whether its stock is fairly valued, overvalued or undervalued, comparing the company against its peers on these metrics gives a good idea of ​​the reasonableness of the stock price .

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to traditional and unconventional valuation metrics to rank stocks from A to F (an A is better than a B; a B is better than a C; and so on), is quite useful in determining whether a stock is overvalued, correctly priced, or temporarily undervalued.

AbbVie is rated B on this front, indicating that it is trading at a discount to its peers. Click here to see values ​​for some of the rating metrics that led to this rating.

Conclusion

The facts discussed here and plenty of other information about Zacks.com might help determine whether it’s worth paying attention to the market buzz about AbbVie. However, its No. 3 Zacks ranking suggests it could perform in line with the broader market in the near term.

Zacks names ‘only one best choice for doubling up’

From thousands of stocks, 5 Zacks experts have each picked their favorite to skyrocket by +100% or more in the coming months. Of these 5, Research Director Sheraz Mian selects one to have the most explosive advantage of all.

It’s a little-known chemical company that’s up 65% year-on-year, but still very cheap. With relentless demand, rising earnings estimates for 2022 and $1.5 billion for stock buybacks, retail investors could step in at any time.

This company could rival or surpass other recent Zacks stocks which are expected to double, such as Boston Beer Company which jumped +143.0% in just over 9 months and NVIDIA which jumped +175.9% in one. year.

Free: See our best stock and our 4 finalists >>

Click to get this free report

AbbVie Inc. (ABBV): Free Stock Analysis Report

To read this article on Zacks.com, click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

]]>
Here’s what to know beyond why Exxon Mobil Corporation (XOM) is a trending stock https://davegplus.com/heres-what-to-know-beyond-why-exxon-mobil-corporation-xom-is-a-trending-stock/ Wed, 04 May 2022 13:00:07 +0000 https://davegplus.com/heres-what-to-know-beyond-why-exxon-mobil-corporation-xom-is-a-trending-stock/ Exxon Mobil (XOM) is one of the most watched stocks by Zacks.com visitors lately. So it might be worth looking at some of the factors that could affect the stock’s short-term performance. Shares of this oil and gas company have returned +6.6% over the past month compared to the -8.1% change in the Zacks S&P […]]]>

Exxon Mobil (XOM) is one of the most watched stocks by Zacks.com visitors lately. So it might be worth looking at some of the factors that could affect the stock’s short-term performance.

Shares of this oil and gas company have returned +6.6% over the past month compared to the -8.1% change in the Zacks S&P 500 composite. The industry Zacks Oil and Gas – Integrated – International, at which owns Exxon, gained 1.3% over this period. Now the key question is: where could the stock be heading in the near term?

Although media reports or rumors of a material change in a company’s business outlook usually cause its stock to trend and result in an immediate price change, there are always certain fundamental factors that ultimately determine the buy and hold decision.

Revisions to earnings estimates

At Zacks, we prioritize evaluating change in a company’s future earnings projection over anything else. This is because we believe that the present value of its future income stream is what determines the fair value of its stock.

We basically look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest trading trends. And if earnings estimates increase for a company, the fair value of its shares increases. A higher fair value than the current market price stimulates investors’ interest in buying the stock, causing its price to rise. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

Exxon is expected to post earnings of $2.79 per share for the current quarter, representing a year-over-year change of +153.6%. Over the past 30 days, the Zacks consensus estimate has changed by +36.2%.

The current year earnings consensus estimate of $10.15 indicates a year-over-year change of +88.7%. This estimate has changed by +30.4% over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $8.76 indicates a change of -13.7% from what Exxon is expected to report a year ago. Over the past month, the estimate has changed by +155.9%.

With a strong externally audited track record, our proprietary stock rating tool, Zacks Rank, provides a more conclusive picture of a stock’s price direction in the short term, as it effectively harnesses the power of earnings estimate revisions. . Due to the magnitude of the recent consensus estimate change, along with three other factors related to earnings estimates, Exxon is ranked Zacks Rank #2 (Buy).

The chart below shows the evolution of the company’s consensus 12-month EPS estimate:

12 month EPS

Revenue Growth Forecasts

While a company’s earnings growth is arguably the best indicator of its financial health, nothing happens if it can’t grow its revenue. It is almost impossible for a company to increase its profits without increasing its revenue for long periods of time. Therefore, knowing the potential revenue growth of a business is crucial.

For Exxon, the consensus sales estimate for the current quarter of $92.05 billion indicates a year-over-year change of +35.9%. For the current and future fiscal years, the estimates of $359.68 billion and $339.74 billion indicate variations of +25.9% and -5.5%, respectively.

Latest reported results and history of surprises

Exxon reported revenue of $90.5 billion last quarter, representing a +53% year-over-year change. EPS of $2.07 for the same period versus $0.65 a year ago.

Compared to the Zacks consensus estimate of $88.88 billion, reported revenue is a surprise of +1.82%. The EPS surprise was -8%.

In the past four quarters, Exxon has exceeded consensus EPS estimates three times. The company has exceeded consensus earnings estimates every time during this period.

Evaluation

Without considering the valuation of a stock, no investment decision can be effective. Crucial to predicting a stock’s future price performance is whether its current price accurately reflects the intrinsic value of the underlying business and the company’s growth prospects.

While comparing the current values ​​of a company’s valuation multiples, such as the price-to-earnings (P/E) ratio, the price-to-sales (P/S) ratio, and the price-to-cash flow (P/CF) ratio , along with its own historical values ​​help determine whether its stock is fairly valued, overvalued or undervalued, comparing the company against its peers on these metrics gives a good idea of ​​the reasonableness of the stock price .

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to traditional and unconventional valuation metrics to rank stocks from A to F (an A is better than a B; a B is better than a C; and so on), is quite useful in determining whether a stock is overvalued, correctly priced, or temporarily undervalued.

Exxon is rated A on this front, indicating that it is trading at a discount to its peers. Click here to see values ​​for some of the rating metrics that led to this rating.

Conclusion

The facts discussed here and plenty of other information on Zacks.com might help determine whether it’s worth paying attention to the market buzz about Exxon. However, its Zacks No. 2 ranking suggests it could outperform the broader market in the near term.

5 shares ready to double

Each was handpicked by a Zacks expert as the #1 preferred stock to earn +100% or more in 2021. Previous recommendations have skyrocketed +143.0%, +175.9%, + 498.3% and +673.0%.

Most of the stocks in this report fly under the radar on Wall Street, which provides a great opportunity to get in on the ground floor.

Today, check out these 5 potential home runs >>

Click to get this free report

Exxon Mobil Corporation (XOM): Free Stock Analysis Report

To read this article on Zacks.com, click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

]]>
Is Trending Stock Bank of America Corporation (BAC) a buy it now? https://davegplus.com/is-trending-stock-bank-of-america-corporation-bac-a-buy-it-now/ Thu, 28 Apr 2022 13:00:07 +0000 https://davegplus.com/is-trending-stock-bank-of-america-corporation-bac-a-buy-it-now/ Bank of America (BAC) recently made it to Zacks.com’s Most Wanted Stock list. Therefore, you may want to consider some of the key factors that may influence the stock’s performance in the near future. Over the past month, shares of this country’s second-largest bank have returned -15.7%, compared to the -7.8% change in the Zacks […]]]>

Bank of America (BAC) recently made it to Zacks.com’s Most Wanted Stock list. Therefore, you may want to consider some of the key factors that may influence the stock’s performance in the near future.

Over the past month, shares of this country’s second-largest bank have returned -15.7%, compared to the -7.8% change in the Zacks S&P 500 composite. industry Zacks Banks – Major Regional, in which Bank of America is located, lost 14.6%. The key question now is: what could be the future direction of the title?

Although press releases or rumors about a substantial change in a company’s business outlook will usually “trend” its stock and cause an immediate price change, there are always fundamental facts that ultimately dominate the take. purchase and retention decision.

Revisions to earnings estimates

At Zacks, we prioritize evaluating change in a company’s future earnings projection over anything else. This is because we believe that the present value of its future income stream is what determines the fair value of its stock.

We basically look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest trading trends. And if earnings estimates increase for a company, the fair value of its shares increases. A higher fair value than the current market price stimulates investors’ interest in buying the stock, causing its price to rise. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and short-term stock price movements.

For the current quarter, Bank of America is expected to post earnings of $0.80 per share, indicating a -22.3% change from the prior year quarter. The Zacks consensus estimate has changed -3.4% over the past 30 days.

The consensus earnings estimate of $3.28 for the current fiscal year indicates a -8.1% year-over-year change. This estimate has changed by +0.3% over the last 30 days.

For the next fiscal year, the consensus earnings estimate of $3.88 indicates a change of +18.2% from what Bank of America is expected to report a year ago. Over the past month, the estimate has changed by +137.6%.

With an impressive externally audited track record, our proprietary stock rating tool – the Zacks Ranking – is a more conclusive indicator of a stock’s short-term price performance, as it effectively harnesses the power of earnings estimate revisions. . The magnitude of the recent change in the consensus estimate, along with three other factors related to earnings estimates, resulted in a Zacks #3 (Hold) ranking for Bank of America.

The chart below shows the evolution of the company’s consensus 12-month EPS estimate:

12 month EPS

Expected revenue growth

While a company’s earnings growth is arguably the best indicator of its financial health, nothing happens if it can’t grow its revenue. It is almost impossible for a company to increase its profits without increasing its revenue for long periods of time. Therefore, knowing the potential revenue growth of a business is crucial.

For Bank of America, the consensus sales estimate for the current quarter of $23.09 billion indicates a year-over-year change of +7.6%. For the current and future fiscal years, the estimates of $93.91 billion and $100.98 billion indicate variations of +5.4% and +7.5%, respectively.

Latest reported results and history of surprises

Bank of America reported revenue of $23.23 billion in the last quarter, representing a year-over-year change of +1.8%. EPS of $0.80 for the same period versus $0.86 a year ago.

Compared to the Zacks consensus estimate of $23.22 billion, reported revenue is a surprise +0.05%. Surprise EPS was +5.26%.

The company has exceeded consensus EPS estimates in each of the past four quarters. The company has exceeded consensus revenue estimates three times during this period.

Evaluation

No investment decision can be effective without considering the valuation of a stock. Whether a stock’s current price accurately reflects the intrinsic value of the underlying business and the company’s growth prospects is a key determinant of its future price performance.

Compare the present value of a company’s valuation multiples, such as its price/earnings (P/E), price/sales (P/S), and price/cash flow (P/CF), to its own historical values ​​help determine whether its stock is fairly priced, overvalued or undervalued, while comparing the company against its peers on these metrics gives a good idea of ​​the reasonableness of its price.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which assesses both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on.), which is useful in determining whether a stock is overvalued, correctly valued, or temporarily undervalued.

Bank of America is rated C on this front, indicating that it trades at par with its peers. Click here to see values ​​for some of the rating metrics that led to this rating.

Conclusion

The facts discussed here and much more information about Zacks.com might help determine whether it’s worth paying attention to the market buzz about Bank of America. However, its No. 3 Zacks ranking suggests it could perform in line with the broader market in the near term.

5 shares ready to double

Each was handpicked by a Zacks expert as the #1 preferred stock to earn +100% or more in 2021. Previous recommendations have skyrocketed +143.0%, +175.9%, + 498.3% and +673.0%.

Most of the stocks in this report fly under the radar on Wall Street, which provides a great opportunity to get in on the ground floor.

Today, check out these 5 potential home runs >>

Click to get this free report

Bank of America Corporation (BAC): Free Stock Analysis Report

To read this article on Zacks.com, click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

]]>
Is Trending Stock JD.com, Inc. (JD) a buy it now? https://davegplus.com/is-trending-stock-jd-com-inc-jd-a-buy-it-now/ Thu, 28 Apr 2022 13:00:07 +0000 https://davegplus.com/is-trending-stock-jd-com-inc-jd-a-buy-it-now/ JD.com, Inc. (JD) is one of the most watched stocks by Zacks.com visitors lately. So it might be worth looking at some of the factors that could affect the stock’s short-term performance. Shares of this company have returned -6.6% over the past month compared to the -7.8% change in the Zacks S&P 500 composite. ., […]]]>

JD.com, Inc. (JD) is one of the most watched stocks by Zacks.com visitors lately. So it might be worth looking at some of the factors that could affect the stock’s short-term performance.

Shares of this company have returned -6.6% over the past month compared to the -7.8% change in the Zacks S&P 500 composite. ., lost 15.9% over this period. Now the key question is: where could the stock be heading in the near term?

Although media reports or rumors of a material change in a company’s business outlook usually cause its stock to trend and result in an immediate price change, there are always certain fundamental factors that ultimately determine the buy and hold decision.

Revisions to earnings estimates

At Zacks, we prioritize evaluating change in a company’s future earnings projection over anything else. This is because we believe that the present value of its future income stream is what determines the fair value of its stock.

Our analysis is primarily based on how sell-side analysts covering the stock revise their earnings estimates to reflect the latest trading trends. When a company’s earnings estimates increase, the fair value of its stock also increases. And when the fair value of a stock is higher than its current market price, investors tend to buy the stock, causing its price to rise. For this reason, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term movements in stock prices.

For the current quarter, JD.com, Inc. is expected to post earnings of $0.35 per share, indicating a -7.9% change from the prior year quarter. The Zacks consensus estimate has changed -8.4% over the past 30 days.

For the current year, the consensus earnings estimate of $1.95 indicates a change of +15.4% from the prior year. Over the last 30 days, this estimate has changed by -0.1%.

For the next fiscal year, the consensus earnings estimate of $2.69 indicates a change of +38% from what JD.com, Inc. is expected to report a year ago. Over the past month, the estimate has changed by +161.1%.

With a strong externally audited track record, our proprietary stock rating tool, Zacks Rank, provides a more conclusive picture of a stock’s price direction in the short term, as it effectively harnesses the power of earnings estimate revisions. . Due to the magnitude of the recent consensus estimate change, along with three other factors related to earnings estimates, JD.com, Inc. is ranked Zacks Rank #5 (Strong Sell).

The chart below shows the evolution of the company’s consensus 12-month EPS estimate:

12 month EPS

Revenue Growth Forecasts

While a company’s earnings growth is arguably the best indicator of its financial health, nothing happens if it can’t grow its revenue. It is almost impossible for a company to increase its profits without increasing its revenue for long periods of time. Therefore, knowing the potential revenue growth of a business is crucial.

For JD.com, Inc., the current quarter sales consensus estimate of $36.95 billion indicates a year-over-year change of +19.2%. For the current and future fiscal years, the estimates of $173.39 billion and $204.85 billion indicate variations of +17.5% and +18.1%, respectively.

Latest reported results and history of surprises

JD.com, Inc. reported revenue of $43.3 billion in the last quarter, representing a year-over-year change of +25.9%. EPS of $0.35 for the same period versus $0.23 a year ago.

Compared to the Zacks consensus estimate of $43.01 billion, reported revenue is a surprise +0.68%. Surprise EPS was +29.63%.

The company has exceeded consensus EPS estimates in each of the past four quarters. The company has exceeded consensus earnings estimates every time during this period.

Evaluation

Without considering the valuation of a stock, no investment decision can be effective. Crucial to predicting a stock’s future price performance is whether its current price accurately reflects the intrinsic value of the underlying business and the company’s growth prospects.

Compare the present value of a company’s valuation multiples, such as its price/earnings (P/E), price/sales (P/S), and price/cash flow (P/CF), to its own historical values ​​help determine whether its stock is fairly valued, overvalued or undervalued, while comparing the company against its peers on these metrics gives a good idea of ​​the reasonableness of its price.

As part of the Zacks Style Scores system, the Zacks Value Style Score (which assesses both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on.), which is useful in determining whether a stock is overvalued, correctly valued, or temporarily undervalued.

JD.com, Inc. is rated B on this front, indicating that it is trading at a discount to its peers. Click here to see values ​​for some of the rating metrics that led to this rating.

Conclusion

The facts discussed here and plenty of other information about Zacks.com might help determine whether it’s worth paying attention to the market buzz about JD.com, Inc. However, its #5 Zacks ranking suggests that it could underperform the broader market in the short term.

5 shares ready to double

Each was handpicked by a Zacks expert as the #1 preferred stock to earn +100% or more in 2021. Previous recommendations have skyrocketed +143.0%, +175.9%, + 498.3% and +673.0%.

Most of the stocks in this report fly under the radar on Wall Street, which provides a great opportunity to get in on the ground floor.

Today, check out these 5 potential home runs >>

Click to get this free report

JD.com, Inc. (JD): Free Stock Analysis Report

To read this article on Zacks.com, click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

]]>
Is Trending Stock Novavax, Inc. (NVAX) a buy it now? https://davegplus.com/is-trending-stock-novavax-inc-nvax-a-buy-it-now/ Wed, 27 Apr 2022 13:00:08 +0000 https://davegplus.com/is-trending-stock-novavax-inc-nvax-a-buy-it-now/ Novavax (NVAX) has been one of the most searched stocks on Zacks.com lately. So, you might want to consider some of the facts that could shape the stock’s performance in the short term. Over the past month, shares of this vaccine maker have returned -39.9%, compared to the -8.1% change in the Zacks S&P 500 […]]]>

Novavax (NVAX) has been one of the most searched stocks on Zacks.com lately. So, you might want to consider some of the facts that could shape the stock’s performance in the short term.

Over the past month, shares of this vaccine maker have returned -39.9%, compared to the -8.1% change in the Zacks S&P 500 composite. During this period, the industry Zacks Medical – Biomedical and Genetics, of which Novavax is a part, lost 7.1%. The key question now is: what could be the future direction of the title?

Although press releases or rumors about a substantial change in a company’s trading outlook will usually “trend” its stock and cause an immediate price change, there are always fundamental facts that ultimately dominate the take. purchase and retention decision.

Revisions to earnings estimates

At Zacks, we prioritize evaluating change in a company’s future earnings projection over anything else. This is because we believe that the present value of its future income stream is what determines the fair value of its stock.

Our analysis is primarily based on how sell-side analysts covering the stock revise their earnings estimates to reflect the latest trading trends. When a company’s earnings estimates increase, the fair value of its stock also increases. And when the fair value of a stock is higher than its current market price, investors tend to buy the stock, causing its price to rise. For this reason, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term movements in stock prices.

For the current quarter, Novavax is expected to post earnings of $3.33 per share, indicating a change of +209.2% from the prior year quarter. The Zacks consensus estimate has changed by +7.4% over the past 30 days.

For the current fiscal year, the consensus earnings estimate of $23.55 indicates a change of +200.5% from the prior year. Over the last 30 days, this estimate has changed by +3.1%.

For the next fiscal year, the consensus earnings estimate of $14.30 indicates a -39.3% change from what Novavax is expected to report a year ago. Over the past month, the estimate has changed by +103.2%.

With a strong externally audited track record, our proprietary stock rating tool, Zacks Rank, provides a more conclusive picture of a stock’s price direction in the short term, as it effectively harnesses the power of earnings estimate revisions. . Due to the magnitude of the recent consensus estimate change, along with three other factors related to earnings estimates, Novavax is ranked Zacks Rank #3 (Hold).

The chart below shows the evolution of the company’s consensus 12-month EPS estimate:

12 month EPS

Expected revenue growth

Although earnings growth is arguably the most superior indicator of a company’s financial health, nothing as such happens if a company is unable to increase revenue. After all, it is almost impossible for a company to increase its profits for an extended period of time without increasing its revenue. It is therefore important to know the potential revenue growth of a business.

For Novavax, the current quarter sales consensus estimate of $878.11 million indicates a year-over-year change of +96.3%. For the current and future fiscal years, the estimates of $4.56 billion and $3.49 billion indicate variations of +298.2% and -23.6%, respectively.

Latest reported results and history of surprises

Novavax reported revenue of $222.2 million last quarter, representing a -20.6% year-over-year change. EPS of -$11.18 for the same period versus -$2.70 a year ago.

Compared to the Zacks consensus estimate of $385.57 million, the reported revenue comes as a surprise of -42.37%. The EPS surprise was -681.82%.

The company couldn’t beat consensus EPS estimates for the past four quarters. The company exceeded consensus revenue estimates only once during this period.

Evaluation

Without considering the valuation of a stock, no investment decision can be effective. Crucial to predicting a stock’s future price performance is whether its current price accurately reflects the intrinsic value of the underlying business and the company’s growth prospects.

While comparing the current values ​​of a company’s valuation multiples, such as the price-to-earnings (P/E) ratio, the price-to-sales (P/S) ratio, and the price-to-cash flow (P/CF) ratio , along with its own historical values ​​help determine whether its stock is fairly valued, overvalued or undervalued, comparing the company against its peers on these metrics gives a good idea of ​​the reasonableness of the stock price .

The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to traditional and unconventional valuation metrics to rank stocks from A to F (an A is better than a B; a B is better than a C; and so on), is quite useful in determining whether a stock is overvalued, correctly priced, or temporarily undervalued.

Novavax is rated B on this front, indicating that it is trading at a discount to its peers. Click here to see values ​​for some of the rating metrics that led to this rating.

Conclusion

The facts discussed here and plenty of other information on Zacks.com might help determine whether it’s worth paying attention to the market buzz about Novavax. However, its No. 3 Zacks ranking suggests it could perform in line with the broader market in the near term.

Zacks names ‘only one best choice for doubling up’

From thousands of stocks, 5 Zacks experts have each picked their favorite to skyrocket by +100% or more in the coming months. Of these 5, Research Director Sheraz Mian selects one to have the most explosive advantage of all.

It’s a little-known chemical company that’s up 65% year-on-year, but still very cheap. With relentless demand, rising earnings estimates for 2022 and $1.5 billion for stock buybacks, retail investors could jump in at any moment.

This company could rival or surpass other recent Zacks stocks which are expected to double, such as Boston Beer Company which jumped +143.0% in just over 9 months and NVIDIA which jumped +175.9% in one. year.

Free: See our best stock and our 4 finalists >>

Click to get this free report

Novavax, Inc. (NVAX): Free Stock Analysis Report

To read this article on Zacks.com, click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

]]>
Here’s what to know beyond why Block, Inc. (SQ) is a trending stock https://davegplus.com/heres-what-to-know-beyond-why-block-inc-sq-is-a-trending-stock/ Mon, 25 Apr 2022 13:00:06 +0000 https://davegplus.com/heres-what-to-know-beyond-why-block-inc-sq-is-a-trending-stock/ Block (SQ) recently made it to Zacks.com’s most searched stock list. Therefore, you may want to consider some of the key factors that may influence the stock’s performance in the near future. Shares of this mobile payment service provider have returned -21.2% over the past month compared to the -5.3% change in the Zacks S&P […]]]>

Block (SQ) recently made it to Zacks.com’s most searched stock list. Therefore, you may want to consider some of the key factors that may influence the stock’s performance in the near future.

Shares of this mobile payment service provider have returned -21.2% over the past month compared to the -5.3% change in the Zacks S&P 500 composite. Zacks’ technology services industry, to which belongs to Block, lost 14.7% over this period. Now the key question is: where could the stock be heading in the near term?

Although press releases or rumors about a substantial change in a company’s trading outlook will usually “trend” its stock and cause an immediate price change, there are always fundamental facts that ultimately dominate the take. purchase and retention decision.

Revisions to earnings estimates

At Zacks, we prioritize evaluating change in a company’s future earnings projection over anything else. This is because we believe that the present value of its future income stream is what determines the fair value of its stock.

Our analysis is primarily based on how sell-side analysts covering the stock revise their earnings estimates to reflect the latest trading trends. When a company’s earnings estimates increase, the fair value of its stock also increases. And when the fair value of a stock is higher than its current market price, investors tend to buy the stock, causing its price to rise. For this reason, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term movements in stock prices.

For the current quarter, Block is expected to post earnings of $0.13 per share, indicating a -68.3% change from the prior year quarter. The Zacks consensus estimate has changed by +47.7% in the last 30 days.

For the current year, the consensus earnings estimate of $1.03 indicates a change of -39.8% from the prior year. Over the last 30 days, this estimate has changed by -135.8%.

For the next fiscal year, the consensus earnings estimate of $1.69 indicates a change of +64.4% from what Block is expected to report a year ago. Over the past month, the estimate has changed by +231.5%.

With an impressive externally audited track record, our proprietary stock rating tool – the Zacks Ranking – is a more conclusive indicator of a stock’s short-term price performance, as it effectively harnesses the power of earnings estimate revisions. . The magnitude of the recent change in the consensus estimate, along with three other factors related to earnings estimates, resulted in a Zacks No. 3 (hold) ranking for Block.

The chart below shows the evolution of the company’s consensus 12-month EPS estimate:

12 month EPS

Expected revenue growth

Although earnings growth is arguably the most superior indicator of a company’s financial health, nothing as such happens if a company is unable to increase revenue. After all, it is almost impossible for a company to increase its profits for an extended period of time without increasing its revenue. It is therefore important to know the potential revenue growth of a business.

For Block, the consensus sales estimate for the current quarter of $4.23 billion indicates a year-over-year change of -16.4%. For the current and future fiscal years, the estimates of $18.91 billion and $24.02 billion indicate variations of +7.1% and +27.1%, respectively.

Latest reported results and history of surprises

Block reported revenue of $4.08 billion in the last quarter, representing a year-over-year change of +29.1%. EPS of $0.27 for the same period versus $0.32 a year ago.

Compared to the Zacks consensus estimate of $3.98 billion, reported revenue is a surprise of +2.43%. Surprise EPS was +42.11%.

Over the past four quarters, Block has exceeded consensus EPS estimates three times. The company has exceeded consensus revenue estimates twice during this period.

Evaluation

Without considering the valuation of a stock, no investment decision can be effective. Crucial to predicting a stock’s future price performance is whether its current price accurately reflects the intrinsic value of the underlying business and the company’s growth prospects.

While comparing the current values ​​of a company’s valuation multiples, such as the price-to-earnings (P/E) ratio, the price-to-sales (P/S) ratio, and the price-to-cash flow (P/CF) ratio , along with its own historical values ​​help determine whether its stock is fairly valued, overvalued or undervalued, comparing the company against its peers on these metrics gives a good idea of ​​the reasonableness of the stock price .

As part of the Zacks Style Scores system, the Zacks Value Style Score (which assesses both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on. ), which helps determine whether a stock is overvalued, correctly valued, or temporarily undervalued.

The block is rated D on this front, indicating that it is trading at a premium to its peers. Click here to see values ​​for some of the rating metrics that led to this rating.

Conclusion

The facts discussed here and plenty of other information about Zacks.com might help determine whether it’s worth paying attention to the market buzz about Block. However, its No. 3 Zacks ranking suggests it could perform in line with the broader market in the near term.

Just Released: Zacks’ 7 Best Stocks For Today

Experts have pulled 7 stocks from the Zacks #1 220 Strong Buys list that have beaten the market more than 2 times with an astonishing average gain of +25.4% per year.

These 7s were selected because of their superior potential for immediate breakout.

See these time-sensitive tickers now >>

Click to get this free report

Block, Inc. (SQ): Free Stock Analysis Report

To read this article on Zacks.com, click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

]]>
Here’s what to know beyond why Avnet, Inc. (AVT) is a trending stock https://davegplus.com/heres-what-to-know-beyond-why-avnet-inc-avt-is-a-trending-stock/ Fri, 22 Apr 2022 13:00:07 +0000 https://davegplus.com/heres-what-to-know-beyond-why-avnet-inc-avt-is-a-trending-stock/ Avnet (AVT) has been one of the most searched stocks on Zacks.com lately. So, you might want to consider some of the facts that could shape the stock’s performance in the short term. Shares of this electronic components distributor have returned -6.6% over the past month compared to the -1.4% change in the Zacks S&P […]]]>

Avnet (AVT) has been one of the most searched stocks on Zacks.com lately. So, you might want to consider some of the facts that could shape the stock’s performance in the short term.

Shares of this electronic components distributor have returned -6.6% over the past month compared to the -1.4% change in the Zacks S&P 500 composite. The industry Zacks Electronics – Parts Distribution, to which Avnet belongs , lost 5.4% over this period. Now the key question is: where could the stock be heading in the near term?

Although media reports or rumors of a material change in a company’s business outlook usually cause its stock to trend and result in an immediate price change, there are always certain fundamental factors that ultimately determine the buy and hold decision.

Revisions to earnings estimates

Rather than focusing on anything else, at Zacks we prioritize assessing change in a company’s earnings projection. Indeed, we believe that the fair value of its shares is determined by the present value of its future earnings streams.

Our analysis is primarily based on how sell-side analysts covering the stock revise their earnings estimates to reflect the latest trading trends. When a company’s earnings estimates increase, the fair value of its stock also increases. And when the fair value of a stock is higher than its current market price, investors tend to buy the stock, causing its price to rise. For this reason, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term movements in stock prices.

For the current quarter, Avnet is expected to post earnings of $1.51 per share, indicating a change of +104.1% from the prior year quarter. The Zacks consensus estimate has remained unchanged for the past 30 days.

The current year earnings consensus estimate of $5.67 indicates a year-over-year change of +109.2%. This estimate has remained unchanged for the past 30 days.

For the next fiscal year, the consensus earnings estimate of $5.64 indicates a change of -0.4% from what Avnet is expected to report a year ago. Over the past month, the estimate has changed by +120%.

With a strong externally audited track record, our proprietary stock rating tool, Zacks Rank, provides a more conclusive picture of a stock’s price direction in the short term, as it effectively harnesses the power of earnings estimate revisions. . Due to the magnitude of the recent consensus estimate change, along with three other factors related to earnings estimates, Avnet is ranked Zacks Rank #4 (Sell).

The chart below shows the evolution of the company’s consensus 12-month EPS estimate:

12 month EPS

Revenue Growth Forecasts

While a company’s earnings growth is arguably the best indicator of its financial health, nothing happens if it can’t grow its revenue. It is almost impossible for a company to increase its profits without increasing its revenue for long periods of time. Therefore, knowing the potential revenue growth of a business is crucial.

For Avnet, the current quarter sales consensus estimate of $5.62 billion indicates a year-over-year change of +14.2%. For the current and future fiscal years, the estimates of $22.7 billion and $22.89 billion indicate variations of +16.2% and +0.8%, respectively.

Latest reported results and history of surprises

Avnet reported revenue of $5.87 billion in the last quarter, representing a year-over-year change of +25.6%. EPS of $1.51 for the same period versus $0.48 a year ago.

Compared to the Zacks consensus estimate of $5.52 billion, reported revenue is a surprise +6.18%. Surprise EPS was +20.8%.

The company has exceeded consensus EPS estimates in each of the past four quarters. The company has exceeded consensus earnings estimates every time during this period.

Evaluation

No investment decision can be effective without considering the valuation of a stock. Whether a stock’s current price accurately reflects the intrinsic value of the underlying business and the company’s growth prospects is a key determinant of its future price performance.

While comparing the current values ​​of a company’s valuation multiples, such as the price-to-earnings (P/E) ratio, the price-to-sales (P/S) ratio, and the price-to-cash flow (P/CF) ratio , along with its own historical values ​​help determine whether its stock is fairly valued, overvalued or undervalued, comparing the company against its peers on these metrics gives a good idea of ​​the reasonableness of the stock price .

As part of the Zacks Style Scores system, the Zacks Value Style Score (which assesses both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on. ), which helps determine whether a stock is overvalued, correctly valued, or temporarily undervalued.

Avnet is rated B on this front, indicating that it is trading at a discount to its peers. Click here to see values ​​for some of the rating metrics that led to this rating.

Conclusion

The facts discussed here and plenty of other information about Zacks.com might help determine whether or not it’s worth paying attention to the market buzz about Avnet. However, its Zacks No. 4 ranking suggests it may underperform the broader market in the near term.

7 best stocks for the next 30 days

Just Released: Experts distill 7 elite stocks from the current Zacks No. 1 Ranking 220 Strong Buys list. They consider these tickers “most likely for early price increases.”

Since 1988, the full list has beaten the market more than 2 times with an average gain of +25.4% per year. So be sure to give your immediate attention to these 7 handpicked ones.

Discover them now >>

Click to get this free report

Avnet, Inc. (AVT): Free Stock Analysis Report

To read this article on Zacks.com, click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

]]>